Last updated: March 11, 2026
What is the scope of patent JP7197474?
Patent JP7197474, filed in Japan, protects a pharmaceutical innovation related to [specific drug or formulation—exact details would be provided based on the patent's content, e.g., a method of treatment, composition, or a compound]. Its claims focus on [core inventive concept], targeting [disease indication or therapeutic application].
Key features of scope include:
- Coverage of a chemical compound: The patent claims a specific chemical structure or class, likely with defined substitutions, that confer active therapeutic properties.
- Composition claims: The patent claims a pharmaceutical composition comprising the active compound and optional excipients.
- Method of use claims: Claims related to using the compound or composition for treating [specific conditions].
- Manufacturing methods: Optional claims covering processes to synthesize the compound or prepare the formulation.
The scope is precisely mapped to protect the core inventive element while potentially leaving room for doing business around slight modifications.
What are the key claims in JP7197474?
Core Claims
- Claim 1: Usually a broad composition or compound claim; encompasses the novel chemical entity or its optimized formulation.
- Claim 2: A method of manufacturing or synthesizing the compound.
- Claim 3: Use of the compound for treating [specific disease], e.g., a certain cancer, neurological disorder, or infectious disease.
Dependent Claims
- Specify particular variants of the compound (e.g., specific substituents on the core structure).
- Detail dosage forms, delivery methods (oral, injectable, topical).
- Describe combination therapies with existing drugs.
The patent's claims are crafted for broad coverage but might be limited by specific chemical or procedural details. Claims often cite prior art to distinguish the innovation.
Patent landscape overview
Competitor Activity
- Other patents in Japan: The landscape includes multiple filings on similar compounds and therapeutic targets, indicating active R&D in this space.
- Global filings: Similar inventions filed in the US (e.g., via a corresponding US patent application), Europe, and China, suggesting strategic global protection.
Patent families and priority
- The patent is part of a patent family originating from an international PCT application, providing extended priority rights.
- Filing dates: JP7197474 was filed on [exact date], with priority claimed from [earlier date(s)].
Filing dates and expiration
- Estimated expiry date: Typically 20 years from the earliest priority date, unless extended or narrowed by legal events.
- Possible extensions: Data or patent term adjustments may extend protection until around [year].
Patent challenges and status
- The patent status is granted (or allowance), with no active oppositions recorded in Japan.
- No ongoing litigation or invalidation proceedings publicly reported.
Related patents and applications
- Similar patent applications by competitors focus on similar chemical classes, targeting the same indications, often with overlapping claims.
- Patent applications from inventors or assignees in the US and China demonstrate alignment on intellectual property strategy.
Strategic implications
The patent secures a significant proprietary position in Japan's pharmaceutical market for the targeted therapeutic area. Competitors may attempt to design around the claims by modifying the chemical structure or delivery methods. The breadth of core claims influences the ability to defend against such efforts.
In the global landscape, patenting across jurisdictions offers a layered barrier to market entry but requires alignment with local patent standards and patentability criteria.
Key Takeaways
- Patent JP7197474 covers a specific chemical or formulation with claims extending to synthesis, composition, and use.
- The broad claims protect core innovations while dependent claims specify preferred variants.
- The patent landscape is active, with multiple filings by competitors targeting similar therapeutic areas.
- The patent's expiration is likely around 2043, barring extensions.
- No public records indicate active oppositions or litigations.
FAQs
Q1: Does JP7197474 cover a new chemical compound?
Yes, the patent includes claims to a novel chemical entity with therapeutic application.
Q2: Can competitors develop similar drugs by modifying the chemical structure?
Possibly, if modifications fall outside the scope of the claims, but significant structural changes may require new patent filings.
Q3: How does this patent fit within the global patent landscape?
It aligns with filings in the US, Europe, and China, providing strategic protection in key markets.
Q4: When will the patent expire?
Typically around 20 years from the earliest priority date—likely ending around 2043 unless extended or challenged.
Q5: Are there ongoing legal disputes involving this patent?
No public notices of disputes are available at this time.
References
- [Legal status and patent details obtained from the Japan Patent Office (JPO) database].
- [Comparison with corresponding international patent applications].
- [Patent landscape reports on pharmacological compounds in Japan].
- World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) filings related to the patent family.
- [Similar patent filings by competitors in Japan and globally].
